Form 4: ACM Research CEO David H. Wang Executes Pre-Planned Stock Sales and Option Exercises

ACM Research, Inc.'s CEO, President, and 10% owner, David H. Wang, reported the exercise of stock options and subsequent sales of Class A Common Stock totaling 130,000 shares over two days, all conducted under a pre-arranged Rule 10b5-1 trading plan.

Summary

• David H. Wang, CEO, President, Director, and 10% Owner of ACM Research, Inc. (ACMR), reported transactions involving the company's Class A Common Stock.
• On May 21, 2025, Mr. Wang acquired 70,000 shares of Class A Common Stock through the exercise of stock options at an exercise price of $1.00 per share.
• Immediately following the option exercise on May 21, 2025, Mr. Wang disposed of 69,992 shares at a weighted average price of $23.60 per share (ranging from $23.00 to $23.99) and an additional 8 shares at a weighted average price of $24.04 per share (ranging from $24.00 to $24.04).
• On May 22, 2025, Mr. Wang acquired another 60,000 shares of Class A Common Stock through the exercise of stock options at an exercise price of $1.00 per share.
• Following this exercise on May 22, 2025, Mr. Wang disposed of 60,000 shares at a weighted average price of $22.63 per share (ranging from $22.43 to $22.99).
• All reported sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Wang on November 29, 2024.
• After these transactions, Mr. Wang's direct beneficial ownership of Class A Common Stock stands at 672,708 shares.
• Mr. Wang also holds indirect beneficial ownership through his wife (100,002 shares), daughter (45,837 shares), a family irrevocable trust (180,000 shares), and a family living trust (620,001 shares), totaling 945,840 indirect shares.
• The stock options exercised were fully vested and exercisable, with an expiration date of December 27, 2026.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the fact that these sales were pre-planned under a 10b5-1 plan mitigates concerns about opportunistic selling. The significant profit from option exercises is a positive for the insider.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, indicating they were pre-scheduled and not a reaction to recent negative company developments.
• The significant difference between the option exercise price ($1.00) and the sale prices (ranging from $22.63 to $24.04) indicates substantial profitability for the insider on these transactions.
• The options exercised were fully vested, demonstrating the long-term commitment and tenure of the CEO.

Negatives

• The disposition of a significant number of shares by a key insider, even if pre-planned, can sometimes be perceived negatively by the market, potentially signaling a lack of confidence or a desire to diversify holdings.

Risks

• While the sales were pre-planned, a large volume of insider selling could still lead to negative market sentiment or put downward pressure on the stock price if investors misinterpret the nature of the transactions.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook. It solely reports past insider transactions.

Management Comments

• The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024.
• The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), and (4) to this Form 4.

Industry Context

This Form 4 filing pertains to specific insider trading activities within ACM Research, Inc. and does not provide information on broader industry trends or competitive landscape. Insider transactions are a routine part of corporate governance and personal financial planning for executives across all industries.

Related Party Transactions

• David H. Wang holds indirect beneficial ownership of Class A Common Stock through his wife, Jing Chen (100,002 shares), his daughter, Sophia Wang (45,837 shares), the David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children (180,000 shares), and the Wang-Chen Family Living Trust (620,001 shares).

Stakeholder Impact

• Shareholders: The pre-planned nature of the sales under a 10b5-1 plan reduces the likelihood of negative market reaction compared to unplanned insider sales, but a large volume of sales by a key executive could still be a point of observation.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

Keywords

ACM Research, ACMR, Form 4, insider trading, stock options, stock sale, David H. Wang, beneficial ownership, 10b5-1 plan, CEO, director, semiconductor equipment